Skin Cancer - High levels of memory killer cells correlate with better survival in melanoma patients
Can't see this email? View it online
   
  Skin Cancer  
  The latest skin cancer news from News Medical  
 
bladder Scientists Integrate Multiple Therapeutic Approaches to More Effectively Target Brain Metastatic Melanomas
 
Acting as a team, twin stem cells activate the immune system to suppress tumor growth and prolong survival in representative preclinical models.
 
 
   High levels of memory killer cells correlate with better survival in melanoma patientsHigh levels of memory killer cells correlate with better survival in melanoma patients
 
Our skin contains specialized long-lived killer cells that protect against intruders. Researchers at Karolinska Institutet in Sweden and the University of Copenhagen in Denmark have now identified how these cells are formed, and shown that high levels of memory killer cells in cancer tissue correlate with a better survival rate in people with melanoma.
 
   Survey reveals the limited knowledge about actinic keratosis among most peopleSurvey reveals the limited knowledge about actinic keratosis among most people
 
Almirall S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, presented today the results of a survey revealing that 85% of respondents are unaware of the existence of actinic keratosis (AK).
 
   Study shows impacts of ASO-based MALAT1-inhibition on MAPK-pathway gene regulation in melanomaStudy shows impacts of ASO-based MALAT1-inhibition on MAPK-pathway gene regulation in melanoma
 
A new research paper was published in Oncotarget's Volume 14 on May 26, 2023, entitled, "Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment."
 
   Researchers use artificial human skin to block invasive tumor growth in skin cancer modelResearchers use artificial human skin to block invasive tumor growth in skin cancer model
 
By using artificial human skin, a research group from the University of Copenhagen have managed to block invasive growth in a skin cancer model.